A series of studies on the isolation and structure elucidation of the sphingolipids from several starfish species have been performed in our laboratory. From the starfish Luidia maculata, we have isolated and characterized one sulfatide molecular species, 1) six cerebrosides, 2) four ceramide lactosides, 3) and three ganglioside molecular species. [4] [5] [6] Continuing the previous studies, the isolation and characterization of ceramides from L. maculata were carried out because of the considerable interest and importance connected with determination of the composition of the mixture of sphingolipids and in the hope of discovering the biologically active compounds from marine natural products.
A series of studies on the isolation and structure elucidation of the sphingolipids from several starfish species have been performed in our laboratory. From the starfish Luidia maculata, we have isolated and characterized one sulfatide molecular species, 1) six cerebrosides, 2) four ceramide lactosides, 3) and three ganglioside molecular species. [4] [5] [6] Continuing the previous studies, the isolation and characterization of ceramides from L. maculata were carried out because of the considerable interest and importance connected with determination of the composition of the mixture of sphingolipids and in the hope of discovering the biologically active compounds from marine natural products.
In this paper, we report on the isolation and structure determination of four ceramides, LMCer-1-1 (1), LMCer-2-1 (2), LMCer-2-6 (3), and LMCer-2-7 (4) from the starfish L. maculata.
The MeOH extract, obtained from the less polar fraction of the CHCl 3 -MeOH extract of the whole bodies of L. maculata, was separated by normal phase silica gel column chromatography to give two substances, LMCer-1 and LMCer-2, which appear as a single spot on the normal phase TLC, and revealed anti-hyperglycemic activity.
7)

Structure of Ceramide Molecular Species LMCer-1
The positive ion FABMS of LMCer-1 exhibited a series of [MϩNa] ϩ ion peaks at m/z 590, 616, 630, 644, 646, 656, 660, 670, 674, and 688. In the 13 C-NMR spectrum, the characteristic signals of a sphingosine-type ceramide possessing 2-hydroxy fatty acid were observed (Table 1) . Therefore, LMCer-1 must be a molecular species of a sphingosine-type ceramide containing 2-hydroxy fatty acid. Furthermore, LMCer-1 was thought to possess normal and ante-iso 8) type side chains since the carbon signals for the terminal methyl groups were observed at d C ϭ14.2 (normal) and d C ϭ11.4, 19.2 (ante-iso) in the 13 C-NMR (Table 1) . The 1 H-NMR signals of the basic structure of LMCer-1 were in good agreement with those of known synthetic ceramide 1b, 9) which is composed of (2S,3R,4E)-sphingosine and (R)-2-hydroxy fatty acid. The above fact and the optical rotation of the LMCer-1 series, LMCer-1-1 (ϩ3.3) (vide infra) and the synthetic ceramide (ϩ7.4) 9) suggested that LMCer-1 has the same absolute configuration as that of the synthetic one for the core structure, the 2,3,2Ј part. The component of LMCer-1 was examined. When LMCer-1 was methanolyzed with methanolic hydrochloric acid, a mixture of fatty acid methyl esters (FAM) was obtained. A gas chromatography-mass spectrometry (GC-MS) analysis of the FAM mixture showed the existence of six components, which were characterized as methyl 2-hydroxypentadecanoate (FAM-1), methyl 2-hydroxyhexadecanoate (FAM-2), 2-hydroxyheneicosanoate (FAM-3), methyl 2-hydroxydocosanoate (FAM-4), methyl 2-hydroxytricosanoate (FAM-5), and methyl 2-hydroxytetracosanoate (FAM-6). The major FAM was methyl 2-hydroxydocosanoate (FAM-4). Therefore, the structure of the ceramide molecular species LMCer-1 was determined to be that shown in Fig. 1 .
Isolation and Structure of Ceramides from LMCer-1 LMCer-1 was separated by reversed-phase HPLC into twelve components, which were recovered to give the twelve fractions LMCer-1-1 to LMCer-1-12. One of the twelve fractions, LMCer-1-1 (1), revealed the single quasi-molecular (Fig. 1) .
Structure of Ceramide Molecular Species LMCer-2 LMCer-2 exhibited a series of [MϩNa] ϩ ion peaks at m/z 608, 622, 650, 664, 678, 692, 706, and 720 in its positive ion FAB-MS. In the 13 C-NMR spectrum, the characteristic signals of phytosphingosine-type ceramide possessing 2-hydroxy fatty acids were observed. Therefore, LMCer-2 must be a molecular species of phytosphingosine-type ceramide containing 2-hydroxy fatty acids. Furthermore, LMCer-2 was thought to possess normal and ante-iso 8) types side chains from the carbon signals for the terminal methyl groups the same as those of LMCer-1 ( Table 1) . The 1 H-NMR signals of the basic structure of LMCer-2 were in good agreement with those of known synthetic ceramide, 10) which is composed of (2S,3S,4R)-phytosphingosine and (R)-2-hydroxy fatty acid. The above fact and the optical rotations of the LMCer-2 series, LMCer-2-1, LMCer-2-6, LMCer-2-7 (ϩ10.1 to ϩ12.8) (vide infra) and the synthetic ceramide (ϩ9.1) 10) suggested that LMCer-2 has the same absolute configuration as that of the synthetic one for the core structure, the 2,3,4,2Ј part. When LMCer-2 was methanolyzed with methanolic hydrochloric acid, a mixture of FAM was obtained. GC-MS analysis of the FAM mixture shows the existence of five components, which were characterized as FAM-2, FAM-3, FAM-4, FAM-5, and FAM-6. The major FAM was FAM-4. Therefore, the structure of the ceramide molecular species LMCer-2 was determined to be that shown in Fig. 1 .
Isolation and Structure of Ceramides from LMCer-2
By means of reversed-phase HPLC, LMCer-2 was separated into thirteen components and they were recovered to give the thirteen fractions LMCer-2-1 to LMCer-2-13. Three of the thirteen fractions, LMCer-2-1 (2), LMCer-2-6 (3), and LMCer-2-7 (4), revealed the single quasi-molecular ion peak To our knowledge, isolation and structure determination of the compounds 1, 2, 3, and 4 has been made for the first time, although 1 and 2 have been reported as major components of ceramide molecular species from the viscera of a Pulmonate Euhadra hickonis.
11) Anti-hyperglycemic activity of the compounds 1-4 will be examined.
Experimental
Melting points were determined on a micro melting point apparatus (Yanako MP-3) without correction. Optical rotations were measured with a Jasco Dip-370 digital polarimeter at 25°C. Separation of LMCer-1 and LMCer-2 Whole bodies of the starfish Luidia maculata (wet weight 57 kg, collected in Hakata Bay in Fukuoka, Japan in May 1995) were homogenized and extracted with CHCl 3 /MeOH (1 : 3, 80 l) followed by further extraction with CHCl 3 /MeOH (1 : 2, 24 l, two times). The combined extracts were concentrated in vacuo to give a condensed extract (2 l). The extract was added to H 2 O (43 l) and this aqueous suspension extracted with AcOEt/n-BuOH (2 : 1, 40 l) for separation of less polar lipids. The organic layer was concentrated in vacuo, and residue was washed with cold acetone (600 ml, four times) to give an acetone-insoluble fraction (337 g). A portion of the acetone-insoluble material (230 g) was partitioned between MeOH and n-hexane (1 : 1, 2 l, two times) Table 1 . Methanolysis of LMCer-1 LMCer-1 (0.5 mg) was heated with 5% HCl in MeOH (0.5 ml) at 80°C for 1 h in a sealed small-volume vial. The reaction mixture was extracted with n-hexane, and the hexane layer was concentrated to give a mixture of FAM for GC-MS analysis. 
GC-MS
Isolation of Ceramides from LMCer-1
The ceramide molecular species LMCer-1 showed 12 peaks in the reversed phase HPLC [column, cosmosil 5C 18 AR-II (10 mmϫ250 mm, Nacalai Tesque); solvent, MeOH; flow rate, 3 ml/min]. Using these conditions, 100 mg of LMCer-1 was separated to give 12 compounds: LMCer-1-1 (1) (4.2 mg, t R ϭ15.0 min), LMCer-1-2 (2.9 mg, t R ϭ16.5 min), LMCer-1-3 (9.8 mg, t R ϭ19.0 min), LMCer-1-4 (1.8 mg, t R ϭ20.5 min), LMCer-1-5 (4.1 mg, t R ϭ22.0 min), LMCer-1-6 (10.6 mg, t R ϭ24.0 min), LMCer-1-7 (6.0 mg, t R ϭ25.2 min), LMCer-1-8 (6.0 mg, t R ϭ27.5 min), LMCer-1-9 (8.6 mg, t R ϭ29.5 min), LMCer-1-10 (2.5 mg, t R ϭ31.5 min), LMCer-1-11 (9.6 mg, t R ϭ34.0 min), LMCer-1-12 (4.8 mg, t R ϭ39.5 min).
LMCer 13 C-NMR: See Table 2 . Compound 1 was methanolyzed using the same method as described for LMCer-1 to yield FAM-2 (methyl 2-hydroxyhexadecanoate).
Methanolysis of LMCer-2 LMCer-2 (0.5 mg) was methanolyzed using the same method as described for LMCer-1 to give a mixture of FAM for GC-MS analysis.
GC-MS Analysis of FAM from LMCer-2 The FAM mixture from LMCer-2 was subjected to GC-MS under the same conditions as that of LMCer-1 to afford FAM-2 (ratio of peak areas, 2), FAM-3 (2), FAM-4 (54), FAM-5 (35), and FAM-6 (7).
Isolation of Ceramides from LMCer-2 The ceramide molecular species LMCer-2 showed 13 peaks in the reversed phase HPLC [column, cosmosil 5C 18 AR-II (10 mmϫ250 mm, Nacalai Tesque); solvent, MeOH; flow rate, 3 ml/min]. Using these conditions, 100 mg of LMCer-2 was separated to give 13 compounds: LMCer-2-1 (2) (1.4 mg, t R ϭ13.0 min), LMCer-2-2 (0.7 mg, t R ϭ14.5 min), LMCer-2-3 (N.D., t R ϭ17.0 min), LMCer-2-4 (N.D., t R ϭ18.0 min), LMCer-2-5 (1.1 mg, t R ϭ19.0 min), LMCer-2-6 (3) (3.7 mg, t R ϭ21.0 min), LMCer-2-7 (4) (12.0 mg, t R ϭ22.0 min), LMCer-2-8 (4.3 mg, t R ϭ24.0 min), LMCer-2-9 (16.7 mg, t R ϭ25.0 min), LMCer-2-10 (2.2 mg, t R ϭ27.0 min), LMCer-2-11 (20.6 mg, t R ϭ29.0 min), LMCer-2-12 (0.9 mg, t R ϭ31.5 min), LMCer-2-13 (9.6 mg, t R ϭ34.0 min).
LMCer-2-1 ( Table 2 . Compound 4 was methanolyzed as above to yield FAM-4 (methyl 2-hydroxydocosanoate).
Biological Activity Anti-hyperglycemic activity of LMCer-1 and LMCer-2 was observed according to the method previously reported.
12) Statistically significant decrease of blood glucose levels and hemoglobin A1c levels were observed in diabetic mice.
